Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

ProQR Therapeutics N.V. buy Raymond James

ProQR Therapeutics N.V.
Start price
€3.19
29.10.24 / 50%
Target price
€12.97
29.10.25
Performance (%)
-30.89%
End price
€2.20
30.10.25
Summary
This prediction ended on 30.10.25 with a price of €2.20. The BUY prediction by Raymond_James for ProQR Therapeutics N.V. performed very badly with a performance of -30.89%. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
ProQR Therapeutics N.V. 1.790% 1.790% -28.100%
iShares Core DAX® 0.224% 2.457% 21.634%
iShares Nasdaq 100 0.371% -0.320% 5.422%
iShares Nikkei 225® 0.972% -0.829% 15.333%
iShares S&P 500 0.417% -0.157% 3.125%

Comments by Raymond_James for this prediction

In the thread ProQR Therapeutics N.V. diskutieren
Prediction Buy
Perf. (%) -30.89%
Target price 12.974
Change
Ends at 29.10.25

ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $14.00 price target on the stock, up previously from $6.00.
Ratings data for PRQR provided by MarketBeat

Raymond James 
0
Report Share
29.10.24
In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) -30.89%
Target price 12.974
Change
Ends at 29.10.25

Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

Raymond James 
0
Report Share
30.10.25

Stopped prediction by Raymond_James for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.27
08.11.23
€3.75
08.11.24
170.93%
09.11.24

Raymond James 
08.11.23 50%